SG Americas Securities »

Aeglea Biotherapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $765k 23k 32.77
2025-03-31 $115k 7.1k 16.15
2024-09-30 $370k 13k 29.39
2024-06-30 $130k 5.5k 23.44